Results 91 to 100 of about 861 (122)

Ziv-aflibercept combined with intravitreal steroid for management of peripheral exudative haemorrhagic chorioretinopathy. [PDF]

BMJ Case Rep, 2019
Balakrishnan D, Oli A.
europepmc   +1 more source

A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic Colorectal Cancer: WJOG 11018G. [PDF]

Target Oncol
Matsumoto T, Yamamoto Y, Kotaka M, Masuishi T, Tsuji Y, Shoji H, Hirata K, Tsuduki T, Makiyama A, Izawa N, Takahashi N, Tsuda M, Yasui H, Ohta T, Kito Y, Otsu S, Hironaka S, Yamazaki K, Boku N, Hyodo I, Yoshimura K, Muro K.   +21 more
europepmc   +1 more source

A Phase I Study of Ganetespib and Ziv-Aflibercept in Patients with Advanced Carcinomas and Sarcomas. [PDF]

Oncologist, 2018
Meehan R, Kummar S, Do K, O'Sullivan Coyne G, Juwara L, Zlott J, Rubinstein L, Doroshow JH, Chen AP.   +8 more
europepmc   +1 more source

Three‐month outcomes of ziv‐aflibercept in the treatment of diabetic macular oedema [PDF]

Acta Ophthalmologica, 2016
Mohammed, Ashraf, Ahmed A R, Souka, Hassan, El Kayal, Mostafa, El Manhaly, Mohamed Hossam, Abdallah   +4 more
openaire   +2 more sources

Intravitreal ziv-aflibercept for recurrent macular edema secondary to central retinal venous occlusion

Indian Journal of Ophthalmology, 2015
Jay Chhablani
doaj   +1 more source

FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial. [PDF]

Cancer, 2019
Cleary JM, Horick NK, McCleary NJ, Abrams TA, Yurgelun MB, Azzoli CG, Rubinson DA, Brooks GA, Chan JA, Blaszkowsky LS, Clark JW, Goyal L, Meyerhardt JA, Ng K, Schrag D, Savarese DMF, Graham C, Fitzpatrick B, Gibb KA, Boucher Y, Duda DG, Jain RK, Fuchs CS, Enzinger PC.   +23 more
europepmc   +1 more source

Comment on: Intravitreal ziv-aflibercept for recurrent macular edema secondary to central retinal venous occlusion

Indian Journal of Ophthalmology, 2015
Alok Sen, Ashish Mitra, Pawan Puneet Malhotra, Sonal Gupta   +3 more
doaj   +1 more source

374 A phase IB trial of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumors

Journal for ImmunoTherapy of Cancer, 2021
Howard Streicher, Michael Manos, Philippe Bedard, Osama Rahma, Andrew Brohl, Kevin Tyan, Scott Rodig, Daniel Renouf, Emma Hathaway, Rachel Cunningham   +9 more
doaj   +1 more source

CLINICAL AND ELECTROPHYSIOLOGICAL EVALUATION AFTER INTRAVITREAL ZIV-AFLIBERCEPT FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION. [PDF]

Retina, 2017
de Oliveira Dias JR, de Andrade GC, Kniggendorf VF, Novais EA, Maia A, Meyer C, Watanabe SES, Farah ME, Rodrigues EB.   +8 more
europepmc   +1 more source

NCI 8628: A randomized phase 2 study of ziv-aflibercept and high-dose interleukin 2 or high-dose interleukin 2 alone for inoperable stage III or IV melanoma. [PDF]

Cancer, 2018
Tarhini AA, Frankel P, Ruel C, Ernstoff MS, Kuzel TM, Logan TF, Khushalani NI, Tawbi HA, Margolin KA, Awasthi S, Butterfield LH, McDermott D, Chen A, Lara PN, Kirkwood JM.   +14 more
europepmc   +1 more source